200: Why 2024 is a make-or-break year for corporate medical groups
Listen now
Description
In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents. In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry. Links: Bold predictions for healthcare in 2024 What you need to know about rising medical group consolidation Physician employment is changing. What does that mean for the industry? Ep. 198: PE firm General Catalyst is buying a hospital — here's our take Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others. Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities. Learn more about Advisory Board Fellowship. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
More Episodes
Generative AI is one of the most widely discussed topics in the industry today. There is continued excitement, mounting anxiety, and dozens of questions for health leaders to answer. While the healthcare industry has been working tirelessly to adapt to the almost unbelievable rate of change, many...
Published 06/25/24
Published 06/25/24
The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations,...
Published 06/18/24